Get started
444

BRIGHTPATH BIOTHERAPEUTICS CO LTD

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

4594 chart

Key stats

Market capitalization
‪4.24 B‬JPY
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−19JPY
Net income
‪−1.49 B‬JPY
Revenue
‪5.28 M‬JPY
Shares float
‪67.94 M‬
Beta (1Y)
0.95

About BRIGHTPATH BIOTHERAPEUTICS CO LTD

Sector
Health Technology
CEO
Kenichi Nagai
Headquarters
Kanagawa
Website
brightpathbio.com
Employees (FY)
32
Founded
2003
ISIN
JP3274140007
FIGI
BBG00B07B4D4
BrightPath Biotherapeutics Co., Ltd. engages in the development of cancer peptide vaccines, which constitute one form of cancer immunotherapy. It has developed ITK-1, a cancer peptide vaccine, which is in phase III clinical study to treat prostate cancer; and GRN-1201 that is in phase II clinical study for the treatment of non-small cell lung cancer, as well as in phase I clinical study to treat melanoma. The company’s products include GRN-1301, a drug resistant tumor-derived neo-antigen for the treatment of non-small cell lung cancer; and iPS-NKT, an induced pluripotent stem cell derived regenerated NKT cell therapy. BrightPath Biotherapeutics was founded by Ito Kyogo on May 8, 2003 and is headquartered in Kanagawa, Japan.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4594 is 57.00 JPY — it has decreased by 5.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange BRIGHTPATH BIOTHERAPEUTICS CO LTD stocks are traded under the ticker 4594.
BRIGHTPATH BIOTHERAPEUTICS CO LTD is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track BRIGHTPATH BIOTHERAPEUTICS CO LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 4594 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIGHTPATH BIOTHERAPEUTICS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
4594 reached its all-time high on Apr 21, 2016 with the price of 2229.00 JPY, and its all-time low was 56.00 JPY and was reached on Apr 5, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 32.00 employees. See our rating of the largest employees — is BRIGHTPATH BIOTHERAPEUTICS CO LTD on this list?